US FDA approves Merck's Winrevair for treatment of adults with pulmonary arterial hypertension

Merck, known as MSD outside of the United States and Canada, announced that the US Food and Drug Administration (FDA) has approved sotatercept-csrk (US Brand Name: Winrevair, for injection, 45mg, [...]